Results There were no differences in oxidative stress biomarkers between treatment groups at baseline
The prevalence and burden of CD remain high because of the lack of understanding of the etiology, medical assessment, and management (Raghunath et al., 2022)
Recalls & Warnings September 01, 2022 Elite One Source Nutritional Services Warned for Manufacturing, Labeling Violations On August 5, 2022, the FDA issued a warning letter to dietary supplement manufacturer Nutritional Laboratories International, Inc
GPER as a therapeutic target Recent advancements in the investigation of GPER agonists (Table 1) and antagonists (Table 2) highlight their emerging roles in the treatment of metabolic diseases
Calcium-based antacids provide an additional source of calcium during pregnancy, which may help prevent hypertension and preeclampsia